Scarica l'app Stockscreener
147.86
0.85%
-1.27
Pre-mercato:
146.00
-1.86
-1.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Borsa (BIIB) Ultime notizie
Analyzing Biogen Inc. with multi timeframe charts2025 Top Gainers & Daily Volume Surge Signals - newser.com
Biogen (BIIB): Reassessing Valuation After Recent Share Price Momentum - simplywall.st
United States Biotechnology Market 2025: Industry - openPR.com
Why Biogen Inc. (IDP) stock stays on top picksWeekly Investment Summary & Safe Capital Growth Tips - newser.com
PEGylated Proteins Market See Incredible Growth 2025-2032 | Biogen Inc, Pfizer Inc, and UCB S.A. - openPR.com
Is Biogen Inc. stock a safe buy before earnings2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
United States Biosimilars Market is expected to reach US$ 171.79 - openPR.com
Nisa Investment Advisors LLC Has $6.39 Million Stock Position in Biogen Inc. $BIIB - MarketBeat
Brighton Jones LLC Purchases New Stake in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a top momentum playJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Biogen Seeks To Stand Out in Lupus With New Anti-CD40L Data - BioSpace
Will Biogen Inc. (IDP) stock benefit from commodity supercycleJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Volatility clustering patterns for Biogen Inc.Earnings Risk Summary & Fast Entry High Yield Tips - newser.com
Will Biogen Inc. (IDP) stock benefit from sector leadershipJuly 2025 Selloffs & Safe Capital Growth Tips - newser.com
Sumitomo Mitsui Trust Group Inc. Decreases Stake in Biogen Inc. $BIIB - MarketBeat
Key metrics from Biogen Inc.’s quarterly dataPortfolio Risk Summary & Technical Pattern Alert System - newser.com
Biogen Inc.’s volatility index tracking explainedMarket Performance Report & Verified Short-Term Plans - newser.com
Historical volatility pattern of Biogen Inc. visualizedLong Setup & Weekly Top Gainers Alerts - newser.com
United States Inflammatory Bowel Disease Market is expected - openPR.com
Will Biogen Inc. stock gain from strong economyJuly 2025 Earnings & Fast Gaining Stock Reports - Fundação Cultural do Pará
Institutional scanner results for Biogen Inc.July 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
Is Biogen Inc. (IDP) stock a buy on weaknessJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
How to escape a deep drawdown in Biogen Inc.Weekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients - TipRanks
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment? - TipRanks
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment? - TipRanks
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment - TipRanks
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients - TipRanks
Biogen’s Study on Diroximel Fumarate: A Closer Look at Pregnancy Outcomes - TipRanks
Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy - TipRanks
Biogen’s Litifilimab Study: A Potential Game-Changer in Lupus Treatment? - TipRanks
Biogen’s Nusinersen Study: Exploring Pregnancy Outcomes in SMA Patients - TipRanks
Biogen’s Innovative Approach in SMA Treatment: ThecaFlex DRx™ System Study Update - TipRanks
Biogen’s Innovative Approach to SMA Treatment: A Study Update - TipRanks
Biogen’s New Study on Omaveloxolone: A Potential Game-Changer for Friedreich’s Ataxia - TipRanks
Biogen’s BIIB142 Study: A New Chapter in Drug Safety Evaluation - TipRanks
Biogen and Denali’s New Study on LRRK2-Associated Parkinson’s Disease: What Investors Need to Know - TipRanks
Biogen’s Innovative Study on Litifilimab Delivery: Market Implications and Study Insights - TipRanks
Biogen, Inc. Experiences Valuation Adjustment Amidst Market Performance Challenges - Markets Mojo
Biogen’s Pregnancy Exposure Study: Implications for MS Treatment Market - TipRanks
Biogen’s Zuranolone Study: A Potential Game-Changer for Postpartum Depression Treatment - TipRanks
Biogen’s Omaveloxolone Study: Assessing Safety During Pregnancy and Lactation - TipRanks
Biogen’s New MS Study: A Potential Game-Changer for Investors? - TipRanks
Biogen’s Omaveloxolone Study: A Closer Look at Long-Term Safety for Friedreich’s Ataxia - TipRanks
Biogen Still Has Competitive Advantages in Neurology, but Its Moat Looks Narrow - Morningstar
Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease - Cantech Letter
Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer's Disease - Newswire Canada
AustralianSuper Pty Ltd Has $92.86 Million Stake in Biogen Inc. $BIIB - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Cuts Stock Position in Biogen Inc. $BIIB - MarketBeat
Using portfolio simulators with Biogen Inc. includedMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com
How Biogen Inc. (IDP) stock behaves in tightening cycles2025 Market Sentiment & Risk Managed Trade Strategies - newser.com
Sector ETF performance correlation with Biogen Inc.Quarterly Investment Review & Entry and Exit Point Strategies - newser.com
0.74%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):